Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.

Abstract:

:Pseudomonas aeruginosa is a leading cause of hospital-acquired infections and is resistant to most antibiotics. With therapeutic options against P. aeruginosa dwindling, and the lack of new antibiotics in advanced developmental stages, strategies for preserving the effectiveness of current antibiotics are urgently required. β-Lactam antibiotics are important agents for treating P. aeruginosa infections, thus, adjuvants that potentiate the activity of these compounds are desirable for extending their lifespan while new antibiotics - or antibiotic classes - are discovered and developed. In this review, we discuss recent research that has identified exploitable targets of cell-wall metabolism for the design and development of compounds that hinder resistance and potentiate the activity of antipseudomonal β-lactams.

journal_name

Future Med Chem

authors

Lamers RP,Burrows LL

doi

10.4155/fmc-2016-0017

subject

Has Abstract

pub_date

2016-06-01 00:00:00

pages

975-92

issue

9

eissn

1756-8919

issn

1756-8927

journal_volume

8

pub_type

杂志文章,评审
  • Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities.

    abstract::Nicotinic receptors are membrane proteins involved in several physiological processes. They are considered suitable drug targets for various CNS disorders or conditions, as shown by the large number of compounds which have entered clinical trials. In recent years, nonconventional agonists have been discovered: positiv...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2017-0169

    authors: Manetti D,Bellucci C,Chiaramonte N,Dei S,Teodori E,Romanelli MN

    更新日期:2018-02-01 00:00:00

  • Development and strategies of VEGFR-2/KDR inhibitors.

    abstract::VEGF is an important signaling protein involved in both vasculogenesis and angiogenesis. As an essential receptor protein tyrosine kinase propagating cellular signal transduction processes, VEGFR-2 is a central target for drug discovery against tumor-associated angiogenesis. Since the autophosphorylation of VEGFR-2 re...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.12.121

    authors: Huang L,Huang Z,Bai Z,Xie R,Sun L,Lin K

    更新日期:2012-09-01 00:00:00

  • Antitubercular and anti-inflammatory properties screening of natural products from Plectranthus species.

    abstract:AIM:Confirm the use of Plectanthus spp. plants in traditional medicine, particularly as anti-inflammatory and anti-infective agents. MATERIALS & METHODS:Compounds previously isolated from Plectranthus spp. were studied for their anti-inflammatory activity using the SNAP assay and RAW 264.7 cells, by the quantification...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2018-0043

    authors: Andrade JM,Custódio L,Romagnoli A,Reis CP,Rodrigues MJ,Garcia C,Petruccioli E,Goletti D,Faustino C,Fimia GM,Rijo P

    更新日期:2018-07-01 00:00:00

  • Equisetin, reutericyclin and streptolodygin as natural product lead structures for novel antibiotic libraries.

    abstract::The emergence of antimicrobial resistance has created a need for the development of novel antibacterial therapies to treat infection. Natural products that exhibit antibacterial activity offer validated starting points for library generation, and the authors report here that small molecule mimics of tetramate-containi...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.15.97

    authors: Jeong YC,Moloney MG

    更新日期:2015-01-01 00:00:00

  • Foamy matters: an update on Quillaja saponins and their use as immunoadjuvants.

    abstract::Immunoadjuvant Quillaja spp. tree saponins stimulate both cellular and humoral responses, significantly widening vaccine target pathogen spectra. Host toxicity of specific saponins, fractions and extracts may be rather low and further reduced using lipid-based delivery systems. Saponins contain a hydrophobic central a...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2018-0438

    authors: Magedans YV,Yendo AC,Costa F,Gosmann G,Fett-Neto AG

    更新日期:2019-06-01 00:00:00

  • Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode.

    abstract:BACKGROUND:The pathogenicity of influenza A and B viruses depends on the function of influenza neuraminidase (NA). Emerging resistant influenza A viruses of subtype H1N1 increasingly challenge the effectiveness of established NA inhibitors. Recent computational studies have indicated several weak points of NA that can ...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.10.292

    authors: Kirchmair J,Rollinger JM,Liedl KR,Seidel N,Krumbholz A,Schmidtke M

    更新日期:2011-03-01 00:00:00

  • Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia model.

    abstract:BACKGROUND:Histone lysine demethylases (KDMs) are well-recognized targets in oncology drug discovery. They function at the post-translation level controlling chromatin conformation and gene transcription. KDM1A is a flavin adenine dinucleotide-dependent amine oxidase, overexpressed in several tumor types, including acu...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2017-0003

    authors: Trifirò P,Cappa A,Brambillasca S,Botrugno OA,Cera MR,Zuffo RD,Dessanti P,Meroni G,Thaler F,Villa M,Minucci S,Mercurio C,Varasi M,Vianello P

    更新日期:2017-07-01 00:00:00

  • Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs.

    abstract::Acetyl-CoA carboxylase (ACC), a critical enzyme in the regulation of fatty acid synthesis and metabolism, has emerged as an attractive target for a plethora of emerging diseases, such as diabetes mellitus, nonalcoholic fatty liver disease, cancer, bacterial infections and so on. With decades of efforts in medicinal ch...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2019-0312

    authors: Wu X,Huang T

    更新日期:2020-03-01 00:00:00

  • Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.

    abstract::Due to the impermeable structure and barrier function of the blood-brain barrier (BBB), the delivery of therapeutic molecules into the CNS is extremely limited. Nanodelivery systems are regarded as the most effective and versatile carriers for the CNS, as they can transport cargo molecules across the BBB via various m...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2018-0208

    authors: Kim KT,Lee HS,Lee JJ,Park EK,Lee BS,Lee JY,Bae JS

    更新日期:2018-11-01 00:00:00

  • Microvascular complications and diabetic retinopathy: recent advances and future implications.

    abstract::Retinal microvascular alterations have been observed during diabetic retinopathy (DR) due to the retinal susceptibility towards subtle pathological alterations. Therefore, retinal microvascular pathology is essential to understand the nature of retinal degenerations during DR. In this review, the role of retinal micro...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.12.206

    authors: Barot M,Gokulgandhi MR,Patel S,Mitra AK

    更新日期:2013-03-01 00:00:00

  • Recent advances in the discovery of small molecule mTOR inhibitors.

    abstract::Mammalian target of rapamycin (mTOR) belongs to the atypical kinase family of phosphatidylinositol-3-kinase-related kinase and function as a master regulators of the switch between catabolic and anabolic metabolism. In the last decade mTOR has emerged as a therapeutic target for various diseases such as cancer, inflam...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.10.233

    authors: Roychowdhury A,Sharma R,Kumar S

    更新日期:2010-10-01 00:00:00

  • Anti-inflammatory effect of novel analogs of natural enkephalinase inhibitors in a mouse model of experimental colitis.

    abstract:AIM:The pharmacotherapy of inflammatory bowel disease is difficult and currently available treatments bring mostly poor and unsatisfactory results. RESULTS:The purpose of this work was the synthesis of opiorphin, sialorphin, spinorphin and a series of their analogs and the in vitro characterization of their effect on ...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2016-0156

    authors: Kamysz E,Sałaga M,Sobocińska M,Giełdoń A,Fichna J

    更新日期:2016-12-01 00:00:00

  • A brief perspective of drug resistance toward EGFR inhibitors: the crystal structures of EGFRs and their variants.

    abstract::The EGFR is one of the most popular targets for anticancer therapies and many drugs, such as erlotinib and gefitinib, have got enormous success in clinical treatments of cancer in past decade. However, the efficacy of these agents is often limited because of the quick emergence of drug resistance. Fundamental structur...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2016-0222

    authors: Guan H,Du Y,Ning Y,Cao X

    更新日期:2017-05-01 00:00:00

  • Proposing advancement criteria for efficient DMPK triage of new chemical entities.

    abstract::With the goal of refining our discovery DMPK workflow, we conducted a retrospective analysis on internal Celgene compounds by calculating the physicochemical properties and gathering data from several assays including solubility, rat and human liver S9 stability, Caco-2 permeability, and rat intravenous (iv.) and oral...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.13.190

    authors: Kulkarni A,Riggs J,Phan C,Bai A,Calabrese A,Shi T,Moghaddam MF

    更新日期:2014-02-01 00:00:00

  • Structural and functional insight of New Delhi Metallo β-lactamase-1 variants.

    abstract::New Delhi Metallo β-lactamase-1 (NDM-1) is a member of the Metallo-β-lactamase family, capable of catalyzing the hydrolysis of all β-lactam antibiotics. The rapid dissemination of NDM producers, 'superbugs', has become a worldwide concern to health workers. Seventeen different variants of NDM have been reported so far...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2017-0143

    authors: Khan S,Ali A,Khan AU

    更新日期:2018-01-01 00:00:00

  • Replacing sulfa drugs with novel DHPS inhibitors.

    abstract::More research effort needs to be invested in antimicrobial drug development to address the increasing threat of multidrug-resistant organisms. The enzyme DHPS has been a validated drug target for over 70 years as the target for the highly successful sulfa drugs. The use of sulfa drugs has been compromised by the wides...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.13.97

    authors: Hammoudeh DI,Zhao Y,White SW,Lee RE

    更新日期:2013-07-01 00:00:00

  • Carbonic anhydrase activators.

    abstract::Mammalian carbonic anhydrases (CAs; EC 4.2.1.1) of which 16 isoforms are known, are involved in important physiological functions. Their inhibition is exploited pharmacologically for the treatment of many diseases (glaucoma, edema, epilepsy, obesity, hypoxic tumors, neuropathic pain, etc.) but the activators were less...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2017-0223

    authors: Supuran CT

    更新日期:2018-03-01 00:00:00

  • Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors.

    abstract::HIV/AIDS remains a formidable disease with millions of individuals inflicted worldwide. Although treatment regimens have improved considerably, drug resistance brought on by viral mutation continues to erode their effectiveness. Intense research efforts are currently underway in search of new and improved therapies. T...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.11.68

    authors: Ghosh AK,Anderson DD

    更新日期:2011-07-01 00:00:00

  • Natural products and ion channel pharmacology.

    abstract::An accelerated rate of natural-product discovery is critical for the future of ion channel pharmacology. For the full potential of natural products to be realized, an interdisciplinary initiative is required that combines chemical ecology and ion channel physiology. A prime source of future drug leads targeted to ion ...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.10.31

    authors: Teichert RW,Olivera BM

    更新日期:2010-05-01 00:00:00

  • Practical applications of matched series analysis: SAR transfer, binding mode suggestion and data point validation.

    abstract:AIM:The assumption in scaffold hopping is that changing the scaffold does not change the binding mode and the same structure-activity relationships (SARs) are seen for substituents decorating each scaffold. Results/methodology: We present the use of matched series analysis, an extension of matched molecular pair analys...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2016-0203

    authors: Hunt P,Segall M,O'Boyle N,Sayle R

    更新日期:2017-01-01 00:00:00

  • Discovery of 1,4-pentadien-3-one derivatives containing quinoxaline scaffolds as potential apoptosis inducers.

    abstract::Aim: To synthesize novel antiproliferative agents. Results & methodology: A variety of 1,4-pentadien-3-one derivatives bearing quinoxaline scaffolds was designed and synthesized and their antiproliferative activities were evaluated. Notably, compounds N3 and N4 exhibited markedly greater antiproliferative activities a...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2019-0371

    authors: Tang X,He J,Li Q,Tang X,Chen M,Hao G,Huai Z,Huang Y,Xue W

    更新日期:2020-08-01 00:00:00

  • Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.

    abstract::Schistosomes, like many eukaryotic pathogens, typically display morphologically distinct stages during their life cycles. Epigenetic mechanisms underlie the pathogens' morphological transformations, and the targeting of epigenetics-driven cellular programs therefore represents an Achilles' heel of parasites. To speed ...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.15.25

    authors: Marek M,Oliveira G,Pierce RJ,Jung M,Sippl W,Romier C

    更新日期:2015-01-01 00:00:00

  • Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review.

    abstract::Diabetes mellitus is an increasing public health problem in the world. Type 2 diabetes is the most common type of diabetes whose complications contribute to its high death rate. It seriously impacts healthcare systems and patients' quality of life. Therefore, effective measures and new treatment strategies are needed ...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2017-0235

    authors: Turdu G,Gao H,Jiang Y,Kabas M

    更新日期:2018-05-01 00:00:00

  • Design of anticancer lysophosphatidic acid agonists and antagonists.

    abstract::Lysophosphatidic acid (LPA) and its receptors, LPA1-6, are integral parts of signaling pathways involved in cellular proliferation, migration and survival. These signaling pathways are of therapeutic interest for the treatment of multiple types of cancer and to reduce cancer metastasis and side effects. Validated ther...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.14.52

    authors: Parrill AL

    更新日期:2014-05-01 00:00:00

  • Fluorine in medicinal chemistry: a century of progress and a 60-year retrospective of selected highlights.

    abstract::This perspective explores the origins of both fluorine and medicinal chemistry a century ago and traces the early history of the intersection of these areas and the subsequent roles that fluorine has played in advancing medicinal innovations and diagnoses during the past 60 years. The overview highlights remarkable br...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.09.65

    authors: Filler R,Saha R

    更新日期:2009-08-01 00:00:00

  • Synthesis of ring-substituted N-benzyl γ-phenyl GABA derivatives via reductive amination.

    abstract:BACKGROUND:GABA derivatives are important for the development of drugs for disorders of the CNS and PNS. RESULTS:We describe a simple synthesis of N-benzyl γ-phenyl-γ-aminobutyric acids, via the reductive amination of the corresponding γ-keto acids with benzylamines using ammonia borane. CONCLUSION:This procedure pro...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.10.300

    authors: Ramachandran PV,Sakavuyi K,Mistry H

    更新日期:2011-02-01 00:00:00

  • Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus(®) library.

    abstract::The current state of antimalarial drug resistance emphasizes the need for new therapies with novel modes of action that will add a significant benefit compared with current standards. In this regard, high throughput phenotypic whole-cell screening aids the discovery of novel antiplasmodial scaffolds that are inherentl...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.12.176

    authors: Paquet T,Gordon R,Waterson D,Witty MJ,Chibale K

    更新日期:2012-12-01 00:00:00

  • Azide-alkyne cycloaddition en route to 4-aminoquinoline-ferrocenylchalcone conjugates: synthesis and anti-TB evaluation.

    abstract:AIM:Tuberculosis is responsible for 9.6 million infections and 1.5 million deaths in 2015. The development of multidrug-resistant and extensively drug-resistant strains has impeded the development of effective antitubercular therapy. Results/methodology: The present manuscript describes the synthesis of a series of 4-a...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2017-0098

    authors: Singh A,Viljoen A,Kremer L,Kumar V

    更新日期:2017-10-01 00:00:00

  • Traditional Tibetan medicinal plants: a highlighted resource for novel therapeutic compounds.

    abstract::Around 70-80% of drugs used in traditional Tibetan medicine (TTM) come from Qinghai Tibet Plateau, the majority of which are plants. The biological and medicinal culture diversity on Qinghai Tibet Plateau are amazing and constitute a less tapped resource for innovative drug research and development. Meanwhile, the pro...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2018-0235

    authors: Hao DC,Xiao PG,Liu C

    更新日期:2018-11-30 00:00:00

  • The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channel.

    abstract:BACKGROUND:The F508del mutation impairs the trafficking of CFTR from endoplasmic reticulum to plasma membrane and is responsible of a severe form of cystic fibrosis. Trafficking can be improved by small organic molecules called 'correctors'. MATERIALS & METHODS:By different synthetic ways, we prepared 4-chloroanisole ...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.14.118

    authors: Nieddu E,Pollarolo B,Mazzei MT,Anzaldi M,Schenone S,Pedemonte N,Pesce E,Galietta LJ,Mazzei M

    更新日期:2014-01-01 00:00:00